Atlas Trials

Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients

Clinical trial NCT03877809 · COMPLETED

Trial details

NCT number
NCT03877809
Sponsor
Rare Partners srl Impresa Sociale
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Beta-Thalassemia
Start date
2019-06-27
Primary completion
2022-04-30
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.